Caraco Pharmaceutical Laboratories, Ltd. (CPD) Gets $188 Million Buyout Bid From Majority Owner Sun Pharmaceutical Industries Ltd  
12/8/2010 8:24:15 AM

PharmaBiz -- Sun Pharmaceutical Industries and Sun Pharma Global Inc have decided to acquire all of the outstanding shares of Caraco Pharmaceutical Laboratories for a per share consideration of $4.75 in cash. This represents a 5 per cent premium over the closing price of Caraco Common Stock on December 2, 2010. The board of director of Caraco will meet today to discuss this proposal and decide the next steps to be taken.